Avaliação econômica de pacientes ambulatoriais portadores de diabetes melito tipo 2 assistidos por um serviço de atenção farmacêutica

Abstract

Objective: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Subjects and methods: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. Results: The pharmaceutical care group had a statistically signifcant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically signifcant increase of 21.3% in the general costs of treatment and visits. Conclusion: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a signifcant increase in general costs.